Medical Devices and Pharma

Medical device and pharmaceutical regulatory consulting and health safety information

FDA and global regulatory affairs, consumer health, and professional development


Expert guidance for industry professionals and clear, reliable information for patients and consumers

Medical Devices
Pharma square image
Biologics Square Image
Combination Products
In Vitro Diagnostics square

Health Alert Regarding Rare Pregnancy Complication

FDA Safety Communication   In a recent health safety alert, the U.S. Food and Drug Administration (FDA) has cautioned healthcare professionals about the rare risk of intrahepatic cholestasis of pregnancy (ICP) associated with the use of thiopurines, including...

Risks with Exactech Equinoxe Shoulder System 

FDA Safety Communication   April 19 Update:  Exactech has initiated a recall to remove Equinoxe Shoulder System devices packaged in the defective bags from facilities’ unused inventory. To see if your device is affected by the recall, visit Exactech’s Recall...

Important Recall Notice for BioMérieux VITEK 2 AST Kit 

Class I Recall Notice   BioMérieux Inc. has issued a crucial recall notice for its VITEK 2 AST kit, a vital tool in determining bacterial susceptibility to antibiotics. The Food and Drug Administration (FDA) classifies this recall as Class I, indicating a severe risk...

SonarMed Inc Recalls Airway Acoustic Sensors

Urgent Class I Recall Notice   SonarMed Inc. has issued a Class I recall for its Airway acoustic sensors due to a critical issue that could lead to serious health consequences for patients. The U.S. Food and Drug Administration (FDA) has identified this as the most...

FDA Alert: Abiomed Impella Blood Pump Controller

Abiomed Impella blood pump controllers Controller May Fail to Detect Device Abiomed has issued an urgent safety notice for its Automated Impella Controller (AIC) due to a potentially serious issue where the system may fail to detect the Impella blood pump when...

GE HealthCare Anesthesia Systems Recall Due to Ventilation Risk

GE Carestation Anesthesia Systems GE HealthCare has issued a high-priority correction for certain Carestation anesthesia systems due to a potentially life-threatening risk when used in Volume Control Ventilation (VCV) mode. Affected Devices Carestation 620, 650, 650c...

FDA Alert: Baxter Recalls Spectrum Infusion Pumps

Baxter Spectrum Infusion Pump Alert Date: July 2025Device: Sigma Spectrum Infusion System (V6 and V8 Platforms)Manufacturer: Baxter HealthcareIssue Type: Urgent Medical Device RecallFDA Status: High-risk; active monitoring in progress The FDA has issued an early alert...

How Unsafe Medical Devices Can Slip Through the Cracks

Healthcare professionals and the device industry share responsibility for timely adverse event reportingGlobal device market withdrawals not always followed in US In a world of global trade and instant communication, you might assume that a medical device deemed...

FDA Approves Xolremdi for WHIM Syndrome 

A Breakthrough for Rare Infections  In a groundbreaking development, the U.S. Food and Drug Administration (FDA) has granted approval for Xolremdi (mavorixafor) capsules, marking a significant milestone in the treatment of WHIM syndrome. Let's delve into what this...

FDA Fast Track Program 

Fast Track for Serious Conditions - Unmet Medical Needs  The FDA's Fast Track program is designed to facilitate the development and expedite the review of drugs and biologics intended to treat serious conditions and fill an unmet medical need. Following are key...

FDA’s Orphan Drug Program

Expedite Development of New Orphan Drugs  The FDA's Orphan Drug Program is designed to encourage the development of drugs and biologics for the treatment, diagnosis, or prevention of rare diseases or conditions, often referred to as orphan diseases. Here are the key...

Rare Pediatric Disease Priority Review Voucher program 

Expedite Development of New Pediatric Drugs  The legislation for priority review of rare pediatric diseases is intended to expedite the development and approval of drugs for serious or life-threatening conditions affecting children. A summary of program and its key...

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Invisible Outbreak of Contaminated Supplement Ingredients

Contaminated Products Distributed Nationwide  How a contaminated Moringa shipment was spread across the U.S. supplement market, and why there were no additional recalls.  Sam’s Club announced a recall of its Member’s Mark Super Greens powder in late October 2025 due...

Organic Moringa Powder Recalled for Salmonella Contamination

On November 12, organic moringa powder importer and packager Africa Imports issued a recall notice for its products dating back to June 5. The recall notice was published on the FDA website. Following are details of the recall. Who Issued the Recall Africa Imports...

FDA Cracks Down on Illegally Marketed 7-OH Products

Unapproved drugs sold online and in retail locations  Yesterday the U.S. Food and Drug Administration (FDA) issued seven warning letters to companies marketing products that contain 7-hydroxymitragynine (7-OH) — a powerful and potentially dangerous opioid-like...

The FDA Orphan Drug Program

Incentives for Rare Disease Drug Development The FDA’s Orphan Drug Program was established to encourage the development of drugs for rare diseases that affect fewer than 200,000 people in the U.S. Because these diseases often lack market incentives due to small...

Global Medical Device Regulation
Global Regulatory
Regulatory Information Management Systems
RIMS Architecture tile square
RIMS for Small and Emerging Businesses
RIMS Readiness Self-Assessment
QMSR Inspections tile
QMSR Implementation Strategies tile
QMSR Terms and Definitions Tile
Affected QMSR regulations and standards tile
QMSR for small manufacturers tile
Medical Device Recalls
Medical Device Warning Letters 1
Pharma Recalls
Pharma Warning Letters
Global Regulatory
Pharma Innovation

Welcome to Medical Devices and Pharma, a website dedicated to providing timely and relevant medical device and pharma information to the regulated medical device and pharmaceutical industries, and consumers of those products.

Our goal is to provide organized, clearly written information from regulatory affairs and consumer perspectives.

  • Key information from the Food and Drug Administration (FDA), the federal regulatory agency responsible for providing oversight over the industries and assuring the safety and efficacy of their products.
  • Regulatory services for compliance, market access, and crisis management
  • Information about innovation, including new products cleared for use in the U.S. market.
  • News stories with topics ranging from product issues to market trends.

Perhaps most importantly, we will strive to maintain vigilance over product issues and their impacts. Check back here for consumer news, product alerts, and current litigation.

Artificial Intelligence

Discover how Artificial Intelligence is revolutionizing the medical device and pharmaceutical industries.

Stay up-to-date with the latest advancements and breakthroughs that are shaping the future of healthcare.

QMSR - Quality Management System Regulation

The U.S. Food and Drug Administration (FDA) has introduced significant updates to its regulatory framework for medical device manufacturers with the transition from the Quality System Regulation (QSR) to the Quality Management System Regulation (QMSR).

This modernization aligns with global standards, streamlining compliance for manufacturers who market devices internationally while maintaining a strong focus on patient safety and product quality.

Quality Management System Regulation - QMSR

Regulatory Information Management Systems - RIMS

Medical Devices
Pharma square image
Combination Products

A veteran-owned business
located in
Iowa’s Cedar Valley